FDA
-
-
-
-
-
-
-
Eledon presents updated kidney transplant drug trial data
-
-
-
-
-
-
-
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
-
-
-
-
-
-
-
Pre-Open Movers: UiPath Sinks Following Results, Coupa Software Gains
-
-
-
-
-
-
-
Eledon Pharmaceuticals (ELDN) Granted FDA Clearance of IND Application to Evaluate Tegoprubart
-
-
-
-
-
-
-
Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart Demonstrating Safety, Target Engagement, and Biomarker Response in Patients Living with Amyotrophic Lateral Sclerosis
-
-
-
-
-
-
-
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

